Touchlight shortlisted for London Award for Innovation - Vote for us!
We are delighted to announce that Touchlight has been shortlisted and is one of the final three candidates picked to win the London Award for Innovation - Vote for Touchlight using the link in this article.
Touchlight awarded Best Emerging UK Synthetic Biotech
We are delighted to announce that Touchlight has been awarded Best Emerging UK Synthetic Biotech Company at the industry-leading OBN awards, reflecting the significant progress we have made in developing our innovative DNA synthesis platform.
Innovate UK funds Touchlight collaboration with Cobra to optimise AAV manufacture
Touchlight are collaborating with Cobra Biologics Ltd (Cobra), international CDMO of biologics and pharmaceuticals on a project to optimise the manufacture of Adeno-Associated Virus (AAV) vectors used in the delivery of gene therapy treatments.
High Quality laboratories established at Touchlight
Touchlight has developed high-quality dbDNA™ production labs at Hampton capable of providing dbDNA™ to future licensees for feasibility studies
University College of London collaboration: dbDNA™ for gene therapy
Touchlight has entered into collaboration with Professor Simon Waddington's group at the University College of London to investigate the potential to generate gene therapy viral vectors using doggybones™ (dbDNA™)